Browse diseases

…r study was conducted, enrolling 271 patients with stage IB–III NSCLC who received neoadjuvant immunochemotherapy. High-resolution CT…

…ential for improving treatment strategies and patient outcomes. Lung cancer, the leading cause of cancer-related deaths, is a focus of rese…

…roduction. Clinical correlations were analyzed in patients with NSCLC treated with EGFR-TKIs.Results Osimertinib triggered NLRP3 infl…

…th NSCLC. To close these research gaps, the Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations (PLuS2) study …

…, we characterize the effect of CH on ICI objective response in non-small cell lung cancer (NSCLC).Methods We performed baseline blood-derived whole-exome…

…l therapy—chiefly radiotherapy—is beneficial in oligometastatic NSCLC. Inconsistent reporting of safety limited quantitative synthesi…

…generation inhibitors.Conclusions In patients with EGFR-mutated NSCLC, first and third generation EGFR tyrosine kinase inhibitors, as…

… checkpoint inhibitors (ICI) improved survival of patients with non-small cell lung cancer (NSCLC), yet many patients do not respond to treatment. The ide…

… compare the 3-year overall survival of patients with stage III NSCLC during follow-up surveillance with [18F]FDG PET/CT versus follo…

…Gastrointestinal metastases from non-small cell lung cancer (NSCLC) are rare and usually focal. Diffuse small bowel involve…

…oteomics shows promise for predicting pCR to nICT in resectable NSCLC and nominates LIF as a predictive, prognostic, and therapeutic …

…rapy for early and locally advanced non-small cell lung cancer (NSCLC). However, these novel drugs are costly, posing a funding chall…